November 3, 2009 issue of the Journal of the American College of Cardiology (JACC), Dr Justin MS Lee (University of Oxford,
UK)
and colleagues report that 2
g of modified-release nicotinic acid (Niaspan, Abbott Laboratories) daily, on top of statins, resulted in a 1.64 mm2 reduction in carotid wall area on MRI, compared with placebo, in patients with vascular disease and low HDL.